The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ACLARIS THERAPEUTICS INC COM 00461U105 8,985 1,500,000 SH   SOLE   1,500,000 0 0
ALLERGAN PLC SHS G0177J108 95,181 650,101 SH   SOLE   650,101 0 0
BRISTOL MYERS SQUIBB CO COM 110122108 47,710 1,000,000 SH Call SOLE   1,000,000 0 0
CHENIERE ENERGY INC COM NEW 16411R208 51,270 750,000 SH   SOLE   750,000 0 0
FGL HLDGS ORD SHS G3402M102 23,610 3,000,000 SH   SOLE   3,000,000 0 0
FOX CORP CL A COM 35137L105 86,978 2,369,331 SH   SOLE   2,369,331 0 0
GOLDMAN SACHS GROUP INC COM 38141G104 33,370 173,811 SH   SOLE   173,811 0 0
GTT COMMUNICATIONS INC COM 362393100 34,700 1,000,000 SH   SOLE   1,000,000 0 0
IRONWOOD PHARMACEUTICALS INC COM CL A 46333X108 66,832 4,939,541 SH   SOLE   4,939,541 0 0
NAVIENT CORPORATION COM 63938C108 7,521 650,000 SH   SOLE   650,000 0 0
PG&E CORP COM 69331C108 71,200 4,000,000 SH   SOLE   4,000,000 0 0
PIONEER NAT RES CO COM 723787107 30,456 200,000 SH   SOLE   200,000 0 0
REVANCE THERAPEUTICS INC COM 761330109 725 46,000 SH   SOLE   46,000 0 0
TAKEDA PHARMACEUTICAL CO LTD SPONSORED ADS 874060205 15,990 785,000 SH   SOLE   785,000 0 0
XPO LOGISTICS INC COM 983793100 45,437 845,500 SH   SOLE   845,500 0 0